UNIGE document Scientific Article
previous document  unige:29907  next document
add to browser collection

Maladie d'Alzheimer: de la pathogénie aux perspectives cliniques

Costanza, A
Published in Revue médicale suisse. 2012, vol. 8, no. 354, p. 1770-2,1774
Abstract The aim of this article is a critical review of the main pathogenetic issues debated in Alzheimer disease, with a focus on the clinical perspectives that could derive from. The pertinence of the amyloid cascade hypothesis as a unique and causal explanation of cognitive deterioration is challenged in the light of recent therapeutic failures of clinical trials and increasing role of tau protein in clinical expression. The detection of very early and possibly preclinical stages of the disease emerges as a necessary condition for the efficacy of future amyloid or tau-oriented curative strategies. In this respect, the possibility of finding individual vulnerability markers--in the group of patients with "mild cognitive impairment" or even in cognitively intact subjects--represents a major challenge of the clinical research in this field.
Keywords Alzheimer Disease/genetics/pathologyAlzheimer VaccinesAmyloid beta-Peptides/immunology/metabolismAmyloid beta-Protein Precursor/geneticsHumansPlaque, Amyloid/pathologyPositron-Emission Tomography
PMID: 23097914
Full text
Article (Published version) (533 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://rms.medhyg.ch/numero-354-page-1770.htm
Research groups Groupe Bouras Constantin (neuropsychiatrie) (1)
Groupe Giannakopoulos Panteleimon (psychiatrie générale) (201)
(ISO format)
COSTANZA, A et al. Maladie d'Alzheimer: de la pathogénie aux perspectives cliniques. In: Revue médicale suisse, 2012, vol. 8, n° 354, p. 1770-2,1774. https://archive-ouverte.unige.ch/unige:29907

404 hits



Deposited on : 2013-09-24

Export document
Format :
Citation style :